Form 4: Allurion Technologies Director Receives Initial Grant of Restricted Stock Units

Keith B Johns II, a director at Allurion Technologies, received an initial grant of 326,086 Restricted Stock Units (RSUs) as part of the company's non-employee director compensation policy.

Summary

• Keith B Johns II, a director of Allurion Technologies, received 326,086 Restricted Stock Units (RSUs) on November 8, 2024.
• These RSUs were granted as part of the company's non-employee director compensation policy and the 2023 Stock Option and Incentive Plan.
• Each RSU represents the right to receive one share of Allurion Technologies' common stock.
• The RSUs will vest in equal annual installments over three years, starting from September 2, 2024, contingent on the director's continued service.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, indicating a positive alignment of interests between the director and the company. There are no negative implications.

Positives

• The grant of RSUs aligns the director's interests with the company's long-term performance.
• The vesting schedule encourages continued service and commitment from the director.

Future Outlook

The RSUs will vest over the next three years, subject to the director's continued service.

Industry Context

The granting of stock-based compensation to directors is a common practice in publicly traded companies to align their interests with shareholders.

Comparison to Industry Standards

• Granting RSUs to non-employee directors is a standard practice in the industry, similar to companies like Medtronic (MDT) and Boston Scientific (BSX), which also use equity-based compensation.
• The three-year vesting period is also typical, aligning with long-term value creation, similar to the vesting schedules used by comparable companies in the medical technology sector.

Stakeholder Impact

• The grant of RSUs aligns the director's interests with those of shareholders, potentially leading to better corporate governance and decision-making.
• The vesting schedule encourages the director's continued service, which can benefit the company and its stakeholders.

Key Dates

Keywords

Restricted Stock Units, RSUs, Director Compensation, Stock Option Plan, Equity Grant, Allurion Technologies, ALUR